Chapman MJ - Search Results

1

A mathematical model for the in vitro kinetics of the anti-cancer agent topotecan.

Evans ND, Errington RJ, Shelley M, Feeney GP, Chapman MJ, Godfrey KR, Smith PJ, Chappell MJ. Evans ND, et al. Among authors: chapman mj. Math Biosci. 2004 Jun;189(2):185-217. doi: 10.1016/j.mbs.2004.01.007. Math Biosci. 2004. PMID: 15094319

2

Structural identifiability for a class of non-linear compartmental systems using linear/non-linear splitting and symbolic computation.

Chapman MJ, Godfrey KR, Chappell MJ, Evans ND. Chapman MJ, et al. Math Biosci. 2003 May;183(1):1-14. doi: 10.1016/s0025-5564(02)00223-7. Math Biosci. 2003. PMID: 12604132

3

The structural identifiability of the susceptible infected recovered model with seasonal forcing.

Evans ND, White LJ, Chapman MJ, Godfrey KR, Chappell MJ. Evans ND, et al. Among authors: chapman mj. Math Biosci. 2005 Apr;194(2):175-97. doi: 10.1016/j.mbs.2004.10.011. Math Biosci. 2005. PMID: 15854675

4

The problem of model indistinguishability in pharmacokinetics.

Godfrey KR, Chapman MJ. Godfrey KR, et al. Among authors: chapman mj. J Pharmacokinet Biopharm. 1989 Apr;17(2):229-67. doi: 10.1007/BF01059030. J Pharmacokinet Biopharm. 1989. PMID: 2677314 Review.

5

Indistinguishability for a class of nonlinear compartmental models.

Chapman MJ, Godfrey KR, Vajda S. Chapman MJ, et al. Math Biosci. 1994 Jan;119(1):77-95. doi: 10.1016/0025-5564(94)90005-1. Math Biosci. 1994. PMID: 8111137

6

A methodology for compartmental model indistinguishability.

Chapman MJ, Godfrey KR. Chapman MJ, et al. Math Biosci. 1989 Oct;96(2):141-64. doi: 10.1016/0025-5564(89)90056-4. Math Biosci. 1989. PMID: 2520195

7

Identifiability and indistinguishability of nonlinear pharmacokinetic models.

Godfrey KR, Chapman MJ, Vajda S. Godfrey KR, et al. Among authors: chapman mj. J Pharmacokinet Biopharm. 1994 Jun;22(3):229-51. doi: 10.1007/BF02353330. J Pharmacokinet Biopharm. 1994. PMID: 7884651 Review.

8

An identifiability analysis of a parent-metabolite pharmacokinetic model for ivabradine.

Evans ND, Godfrey KR, Chapman MJ, Chappell MJ, Aarons L, Duffull SB. Evans ND, et al. Among authors: chapman mj. J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):93-105. doi: 10.1023/a:1011521819898. J Pharmacokinet Pharmacodyn. 2001. PMID: 11253617

9

The impact of a tailored nutrition intervention delivered for the duration of hospitalisation on daily energy delivery for patients with critical illness (INTENT): a phase II randomised controlled trial.

Ridley EJ, Bailey M, Chapman MJ, Chapple LS, Deane AM, Gojanovic M, Higgins AM, Hodgson CL, King VL, Marshall AP, Miller EG, McGuinness SP, Parke RL, Paul E, Udy AA; Australian, New Zealand Intensive Care Society Clinical Trials Group. Ridley EJ, et al. Among authors: chapman mj. Crit Care. 2025 Jan 6;29(1):8. doi: 10.1186/s13054-024-05189-3. Crit Care. 2025. PMID: 39762887 Free article. Clinical Trial.

10

Nutrition provision over time in longer stay critically ill patients: A post hoc analysis of The Augmented vs Routine Approach to Giving Energy Trial.

Viner Smith E, Lange K, Peake S, Chapman MJ, Ridley EJ, Rayner CK, Chapple LS. Viner Smith E, et al. Among authors: chapman mj. JPEN J Parenter Enteral Nutr. 2024 Dec 20. doi: 10.1002/jpen.2717. Online ahead of print. JPEN J Parenter Enteral Nutr. 2024. PMID: 39704108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters